Cantrell Drug Company to utilize closed vial filling system for enhanced sterility assurance

Cantrell Drug Company in Little Rock, Ark., will become the first human drug compounding outsourcing facility in the United States to use Belgium-based Aseptic Technologies’ closed vial system for sterile filling of injectable drugs.

Advertisement

Aseptic Technologies’ Crystal Closed Vial Technology reduces the risk of contamination during the compounding process, using lasers to reseal vials once they have been filled with medication.

“This technology represents a revolutionary advance for Cantrell Drug Company, as well as for the sterile product industry in general,” said Dell McCarley, CEO of Cantrell Drug Company.

More articles on pharmaceuticals:

FDA warns not to use sterile products from Downing Labs due to lack of quality assurance
340B Program: Time to recertify
Pharma recalls steady, but increasing in complexity

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.